Cargando…
Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression
Targeted therapies are considered to be the future of cancer treatment. However, the mechanism through which intracellular signaling pathways coordinate to modulate oncogenesis remains to be elucidated. In this study, we describe a novel crosstalk among ERK, AKT and Hippo-YAP pathways, with CD44 as...
Autores principales: | Yu, Shiyi, Cai, Xiuxiu, Wu, Chenxi, Wu, Lele, Wang, Yuzhi, Liu, Yan, Yu, Zhenghong, Qin, Sheng, Ma, Fei, Thiery, Jean Paul, Chen, Liming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413630/ https://www.ncbi.nlm.nih.gov/pubmed/25605020 |
Ejemplares similares
-
Upstream regulators of the Hippo pathway
por: Yu, Fa-Xing, et al.
Publicado: (2012) -
Oncogenic Protein Kinase D3 Regulating Networks in Invasive Breast Cancer
por: Liu, Yan, et al.
Publicado: (2017) -
ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling
por: Yu, Shiyi, et al.
Publicado: (2019) -
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
por: Zhang, Jun, et al.
Publicado: (2021) -
YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)